NCT00440115View on ClinicalTrials.gov

Disease Management for Smoking Cessation

PHASE3CompletedINTERVENTIONAL
Enrollment

750

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Smoking Cessation
Interventions
BEHAVIORAL

High intensity disease management

Health education mailings, 6 motivation interviews/counseling

BEHAVIORAL

Low intensity disease management

Health education mailings, one motivation interview/counseling

BEHAVIORAL

Comparison group

Health education mailings

DRUG

Bupropion

Buproprion or Nicotine Replacement Therapy

Trial Locations (1)

66160

University of Kansas Medical Center, Kansas City

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

GlaxoSmithKline

INDUSTRY

lead

University of Kansas Medical Center

OTHER